Tumor-related symptoms (TRS) assessment in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with gefitinib or erlotinib: Preliminary results of an observational study.
Giovanni Mansueto
No relevant relationships to disclose
Filomena Narducci
No relevant relationships to disclose
Silvia Quadrini
No relevant relationships to disclose
Lucia Mentuccia
No relevant relationships to disclose
Roberta Grande
No relevant relationships to disclose
Isabella Sperduti
No relevant relationships to disclose
Teresa Gamucci
No relevant relationships to disclose